Cardiac contractility modulation for heart failure: A meta-analysis of randomized controlled trials

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 9, 2012, Pages 1111-1118

  Kwong, Joey S W ^a   Sanderson, John E ^a   Yu, Cheuk Man ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

congestive heart failure; data analysis; rate modulation

Indexed keywords

ARTICLE; CARDIAC CONTRACTILITY MODULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL; SHAM PROCEDURE;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HOSPITALIZATION; HUMANS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866175578     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03449.x     Document Type: Article

References (41)

1. Norton C, Georgiopoulou VV, Kalogeropoulos AP, Butler J,. Epidemiology and cost of advanced heart failure. Prog Cardiovasc Dis 2011; 54: 78-85.
2. Braunschweig F, Cowie MR, Auricchio A,. What are the costs of heart failure? Europace 2011; 13: II13-II17.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, et al,. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121: e46-e215.
4. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, et al,. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011; 123: e18-e209.
5. Zannad F, Agrinier N, Alla F,. Heart failure burden and therapy. Europace 2009; 11: 1-9.
6. Mancini D, Burkhoff D,. Mechanical device-based methods of managing and treating heart failure. Circulation 2005; 112: 438-448.
7. Abraham W, Fisher W, Smith A, Delurgio D, Leon A, Loh E, Kocovic DZ, et al,. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
8. Bristow M, Saxon L, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, et al,. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
9. Cleland J, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, et al,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
10. Yip GW, Fung JWH,. Cardiac resynchronisation therapy for heart failure with narrow or normal QRS. Heart 2011; 97: 1029-1031.
11. Zhang Q, Yu C,. Could exercise unveil the mystery of non-response to cardiac resynchronization therapy? Europace 2011; 13: 768-769.
12. Burkhoff D, Ben-Haim SA,. Nonexcitatory electrical signals for enhancing ventricular contractility: Rationale and initial investigations of an experimental treatment for heart failure. Am J Physiol Heart Circ Physiol 2005; 288: H2550-H2556.
13. Callans DJ, Fuchs S, Mika Y, Shemer I, Aviv R, Haddad W, Darvish N, et al,. Global improvement in left ventricular performance observed with cardiac contractility modulation is the result of changes in regional contractility. Heart Fail Rev 2001; 6: 35-44.
14. Butter C, Rastogi S, Minden HH, Meyhofer J, Burkhoff D, Sabbah HN,. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 2008; 51: 1784-1789.
15. Lawo T, Borggrefe M, Butter C, Hindricks G, Schmidinger H, Mika Y, Burkhoff D, et al,. Electrical signals applied during the absolute refractory period: An investigational treatment for advanced heart failure in patients with normal QRS duration. J Am Coll Cardiol 2005; 46: 2229-2239.
16. Winter J, Brack KE, Ng GA,. Cardiac contractility modulation in the treatment of heart failure: Initial results and unanswered questions. Eur J Heart Fail 2011; 13: 700-710.
17. Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC, Mika Y, et al,. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol 2007; 49: 2120-2128.
18. Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco E, Goldstein S, Ben-Haim S, et al,. Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur J Heart Fail 2004; 6: 145-150.
19. Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco E, Sharov V, Goldstein S, et al,. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail 2003; 9: 69-75.
20. Sabbah HN, Haddad W, Mika Y, Nass O, Aviv R, Sharov VG, Maltsev V, et al,. Cardiac contractility modulation with the impulse dynamics signal: Studies in dogs with chronic heart failure. Heart Fail Rev 2001; 6: 45-53.
21. Brunckhorst CB, Shemer I, Mika Y, Ben-Haim SA, Burkhoff D,. Cardiac contractility modulation by non-excitatory currents: Studies in isolated cardiac muscle. Eur J Heart Fail 2006; 8: 7-15.
22. Mohri S, Shimizu J, Mika Y, Shemer I, Wang J, Ben-Haim SA, Burkhoff D,. Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart. Am J Physiol Heart Circ Physiol 2003; 284: H1119-H1123.
23. Meyer C, Rana OR, Saygili E, Gemein C, Becker M, Nolte KW, Weis J, et al,. Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation. Circulation 2010; 121: 1286-1294.
24. Naegele H, Behrens S, Eisermann C,. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace 2008; 10: 1375-1380.
25. Pappone C, Rosanio S, Burkhoff D, Mika Y, Vicedomini G, Augello G, Shemer I, et al,. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2002; 90: 1307-1313.
26. Pappone C, Augello G, Rosanio S, Vicedomini G, Santinelli V, Romano M, Agricola E, et al,. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: Mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol 2004; 15: 418-427.
27. Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Böcker D, Wichter T, et al,. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J 2004; 25: 650-655.
28. Radlberger P, Adlbrecht C, Mittermayr T,. Cardiac contractility modulation in patients with heart failure refractory to drug treatment. Exp Clin Cardiol 2011; 16: 43-46.
29. Higgins JPT, Altman DG, Sterne JAC, (eds). Assessing risk of bias in included studies. In:, Higgins JPT, Green S, (eds): Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: http://www.cochrane-handbook.org (accessed November 25, 2011).
30. Moher D, Liberati A, Tetzlaff J, Altman DG,; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151: 264-269.
31. Neelagaru SB, Sanchez JE, Lau SK, Greenberg SM, Raval NY, Worley S, Kalman J, et al,. Nonexcitatory, cardiac contractility modulation electrical impulses: Feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm 2006; 3: 1140-1147.
32. Neelagaru SB, Sanchez JE, Lau SK, Greenberg SM, Raval NY, Worley S, Kalman J, et al,. Non-excitatory, cardiac contractility modulation electrical impulses: Feasibility study for advanced heart failure in patients with normal QRS duration (abstract). J Card Fail 2006; 12: S74-S74.
33. Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, et al,. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 2008; 29: 1019-1028.
34. Abraham WT, Burkhoff D, Nademance K, Carson P, Bourge R, Ellenbogen KA, Parides M, et al,. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics. Am Heart J 2008; 156: 641-648.
35. Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, et al,. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 2011; 161: 329-337.e1- 2.
36. Cleland JG, Coletta AP, Clark AL, Cullington D,. Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA. Eur J Heart Fail 2009; 11: 622-630.
37. Abraham WT, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, et al,. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail 2011; 17: 710-717.
38. Kadish AH, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, et al,. Cardiac contractility modulation improves exercise tolerance in NYHA class III patients with narrow QRS and EF between 25 and 35%: A subgroup analysis of the FIX-HF-5 study (abstract). Circulation 2009; 120: S824-S824.
39. NCT01381172. Evaluate safety and efficacy of the OPTIMIZER® system in subjects with NYHA class III heart failure symptoms: FIX-HF-5B. Available at: http://clinicaltrials.gov/ct2/show/NCT01381172 (accessed November 27, 2011).
40. Schau T, Seifert M, Meyhfer J, Neuss M, Butter C,. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace 2011; 13: 1436-1444.
41. Yu CM, Chan JY, Zhang Q, Yip GW, Lam YY, Chan A, Burkhoff D, et al,. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging 2009; 2: 1341-1349.